Theranica

Traumatic brain injuries (TBI), a frequent injury experienced by veterans, have been linked to either triggering or exacerbating pre-existing migraine disease. One study that followed veterans with deployment-related TBI for 4–11 years after injury reported more frequent and severe headaches compared to veterans without TBI. 89% of these veterans experienced PTH (post traumatic headache) with a phenotype of migraine [1]. Veterans living with TBI are also:  - Twice as likely to live with depression and/or a substance use disorder. - Three times more likely to experience post-traumatic stress disorder (PTSD). Amid these challenges, veterans can face risk of MoH due to frequent use of contributing medications. Additionally, if their migraine is not treated properly, the veterans are at risk of migraine chronification [2]. This is where a drug-free, non-disruptive treatment like the REN wearable comes in.* The Nerivio® REN wearable harnesses the brain’s natural pain management abilities to treat migraine pain and related symptoms without the need for prescription medications, minimizing potential side effects and lowering the risk of MOH. BONUS: Nerivio is covered under VA benefits, ensuring our veterans have access to effective, safe migraine treatment. Learn more here: https://lnkd.in/eGWuyXDk — 1. Couch et al, “Headache Prevalence at 4-11 Years After Deployment-Related Traumatic Brain Injury in Veterans of Iraq and Afghanistan Wars and Comparison to Controls: A Matched Case-Controlled Study” 2. Gaseperi et al, “Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans” *Nerivio® is a neuromodulation device indicated for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age and up. Nerivio can be obtained with a medical prescription. As with any therapy, there may be side effects and contraindications. Not all patients respond to the therapy in the same way, meaning that treatment results can vary individually. Consult with your healthcare provider to see if Nerivio is right for you. More information about Nerivio can be found here: Nerivio.com.

What’s Missing in Adolescent Migraine Treatment? When it comes to treating migraine in adolescents, the options are often limited. Many prescription medications have not been specifically evaluated for this age group or were not originally developed for migraine treatment. In addition, prescription medications often come with poor tolerability and disruptive side effects, requiring adult supervision and strict compliance to minimize adverse reactions. This can hinder timely intervention and adherence to treatment plans, exacerbating the condition and its negative impact on adolescents' lives. This is where the Nerivio® REN wearable comes in—a drug-free, safe, and effective option that addresses the unmet needs of this patient population. It harnesses the brain’s natural pain management abilities, offering a non-drug, non-disruptive alternative to treat and reduce the disability and burden of migraine disease in adolescents and young adults. Learn about how the REN wearable can change how providers can treat adolescent migraine: Nerivio.com

Advocating for Migraine Treatment: Addressing Insurance Barriers Insurance delays, denials, and switching are more than just minor inconveniences. These practices deeply impact migraine patients’ quality of life and put a heavy burden on the healthcare system. The consequences? Treatment delays, more severe and frequent migraine attacks, and increased visits to the ER, urgent care, and unplanned doctor appointments. Patients miss school, work, social gatherings, and precious time with family, which can lead to both financial and emotional strain. If you or someone you know has been denied access to migraine treatment, it’s time to take action. Learn how with this toolkit from Migraine Meanderings and The Headache & Migraine Policy Forum: https://lnkd.in/eACTa5NF

In a recent webinar from Migraine Disorders, Dr. Deanna Duggan, a neurology specialist from Texas Children’s Hospital, highlighted the Nerivio® REN wearable as a game-changer  for families hesitant to use daily preventive and acute migraine medications, which may have side effects that can disrupt adolescents’ routines.* As a dual-use migraine treatment, the Nerivio REN wearable is FDA-cleared and supported by 21 clinical publications that demonstrate robust evidence of efficacy and safety. Adolescents ages 12 and up who are diagnosed with migraine can use the REN wearable for prevention and acute treatment to manage their migraine disease independently and without disruption. The Nerivio REN wearable is a drug-free, dual-use treatment option that can easily integrate into an adolescent’s treatment plan so they can take control of their migraine right from their smartphone.  Watch the full webinar here: https://lnkd.in/erfbdqhF  — *Nerivio® is a neuromodulation device indicated for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age and up. Nerivio can be obtained with a medical prescription. As with any therapy, there may be side effects and contraindications. Not all patients respond to the therapy in the same way, meaning that treatment results can vary individually. Consult with your healthcare provider to see if Nerivio is right for you. More information about Nerivio can be found here: Nerivio.com.

Recent findings from a study by Shao, et al. published in “Headache: The Journal of Head & Face Pain” highlight migraine preventive treatments significantly improve functional ability, correlating to reduced headache frequency and less severe symptoms of depression [1]. As a dual-acting treatment, the Nerivio® REN wearable can be used for prevention to effectively reduce the frequency, duration, or severity of migraine. As a drug-free treatment, it carries no risk of Medication Overuse Headache (MoH). Unfortunately, many health plans overlook the efficacy and safety associated with Nerivio, which is why advocating for coverage is crucial. It’s time for insurers to recognize effective, drug-free treatments like the Nerivio REN wearable and expand coverage to ensure underserved patient populations, like adolescents, have access to the care they need. Learn more about the REN wearable here: Nerivio.com — 1.Samantha C. Shao et al, “Headache, The Journal of Face and Pain”

Daniel Lax, MD, Assistant Professor of Neurology and Pediatrics at Montefiore Einstein in NYC, provided input about the groundbreaking benefits of the Nerivio® REN wearable in migraine care, addressing the unmet need for better treatment options for underserved populations, like adolescents. Dr. Lax emphasized, “Recognizing the significant impact of migraine disease on functionality, quality of life, and healthcare costs, I view Nerivio as a transformative treatment for adolescents and young adults. Its capacity to mitigate adverse effects, prevent escalation, and deliver essential relief positions it as a game-changer in migraine management.” Learn more about how the Nerivio REN wearable is revolutionizing migraine treatment for adolescents and young adults with drug-free, non-disruptive relief: Nerivio.com

Students living with migraine disease face substantial stress when thinking about heading back to school. These adolescents deserve to be set up for success with a migraine treatment that allows them to participate in day-to-day activities the same way any other student would—without going to the school nurse for dosing or even missing class. That’s why we designed the Nerivio® REN wearable with these three benefits to send students back to school with confidence: - Drug-free: Treatment with the REN wearable can be done right in the classroom and under clothing, allowing students to discreetly manage their migraine without disrupting their day. - Hassle-free: The REN wearable is self-administered and does not require water or gel application. It is also controlled through a smartphone app, making it easy for students to manage their treatment independently.  - Safe: The REN wearable allows students to stay present and participate without the unwanted systemic side effects often associated with prescription medications. Here's to making this school year a great one—for everyone! Learn more here: Nerivio.com 

We’re excited to announce that we’ve expanded our GIER (Guided Imagery, Education, and Relaxation) feature in the Nerivio app with leading headache psychologists, Dawn C. Buse, PhD, and Dr. Elizabeth Seng! What is GIER? GIER offers guided and educational videos to enhance the Nerivio® REN wearable treatment. Research shows that combining GIER with Nerivio leads to better pain relief than REN alone and faster return to normal activities [1]. The new GIER UP! video library was designed to complement acute and/or preventive Nerivio treatments. The library features 14 sessions totaling nearly 7 hours of content in 3 unique programs: - Guided Treatment Companion: Engaging videos and visualizations of brain activity during migraine and how Nerivio works. - Behavioral Migraine Management: Interactive sessions on migraine management principles and practical application. - Relaxation, Rejuvenation & Resilience: Sessions designed for muscle relaxation and breathing to rejuvenate your mind, and boost your nervous system's resilience. The ‘GIER UP!’ video library is available free of charge during treatment. Learn more here: https://lnkd.in/ewNv68Cg — 1.Buse et al., Pain Medicine, 2022

Research shows that empathic care in medicine is associated with greater patient satisfaction and adherence.[1] In that spirit, we wanted to share one patient's honest perspective of what she wishes her provider understood about living with migraine: “Dear Neurologist, I am writing to share the emotional journey of living with chronic migraine and seeking your care. While you see many patients, you are the only neurologist I have. My life with migraine is far from ‘routine.’ I feel terrified, exhausted, and desperate by the time I reach your door. I’ve been through numerous doctors and treatments, each leaving me more drained. Despite this, I remain hopeful that you will offer a solution. Please understand my fears, frustrations, and hopes as you treat me. Your expertise and compassion can make a profound difference in my life.” You can read the full letter for a deeper understanding of how you can better support patients like Linda here: https://lnkd.in/d3GNriNF. — 1: The Mindful Migraine Blog, “A Letter to Neurologists”

Research indicates [1] that veterans with headache disorders are more prone to accompanying pain and sleep disorders, traumatic brain injuries (TBI), and PTSD diagnoses. Yet, despite these findings, migraine, a prevalent headache disorder, often remains underdiagnosed. This underscores the urgent need for increased awareness and support for our veteran community, especially when it comes to managing migraine and related symptoms. The stigma surrounding migraine can further complicate access to necessary treatment, exacerbating the challenges our veterans already face. Organizations like the American Migraine Foundation continue to raise awareness and provide resources for our veterans living with migraine. We’re proud to say that the Nerivio® REN wearable is a safe, effective and non-disruptive treatment option covered under VA benefits to address the unmet needs for this patient population.  Learn more here: https://lnkd.in/eGWuyXDk — 1. Nadir M. Balba, et al, “Increased Sleep Disturbances and Pain in Veterans With Comorbid Traumatic Brain Injury and Posttraumatic Stress Disorder”